Skip to content

Clinical trials

Phase 2 Conjunctivitis, Allergic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Conjunctivitis, Allergic Phase: Phase 2 Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20093
20104
20113
20121
20131
20162
20173
20181
20201
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Telios Pharma, Inc.4
Bausch & Lomb Incorporated3
Faes Farma, S.A.2
Fovea Pharmaceuticals SA2
Aciex Therapeutics, Inc.1
Aldeyra Therapeutics, Inc.1
C.T. Development America, Inc.1
Christopher Thompson, MD1
Eye Therapies, LLC1
Koffler Vision Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Conjunctivitis, Allergic24
Hypersensitivity2
Rhinitis, Allergic, Seasonal2
Conjunctivitis1
Rhinitis, Allergic1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.